Allergy

Citations 1-9 of 9 total displayed.

Most recent content (1 Feb 2007):

Therapeutics
Review: omalizumab reduces exacerbation and steroid use in chronic asthma

P John Rees
Evid Based Med 2007; 12: 11. [Extract] [Full text]  

Therapeutics
Environmental and dietary interventions in the first 5 years of life did not reduce risk of asthma and allergic disease

Thomas M Ball
Evid Based Med 2007; 12: 19. [Extract] [Full text]  

Past content (since Mar 2000):

Therapeutics
Sublingual immunotherapy with a grass allergen tablet improved symptoms and quality of life in allergic rhinoconjunctivitis

Frank Thien
Evid Based Med 2006; 11: 173. [Extract] [Full text]  

Therapeutics
2 year inhaled corticosteroid therapy did not prevent asthma in high risk preschool children after treatment was discontinued

Bruce Mazer
Evid Based Med 2006; 11: 174. [Extract] [Full text]  

Therapeutics
Review: allergen specific immunotherapies reduce symptoms, medication requirements, and bronchial hyper-reactivity in asthma

Bernard R Adelsberg
Evid Based Med 2004; 9: 114. [Extract] [Full text]  

Therapeutics
Review: long acting ß₂ agonists are better than short acting ß₂ agonists in chronic asthma

Joseph A Golish
Evid Based Med 2003; 8: 145. [Extract] [Full text]  

Therapeutics
Prenatal and postnatal administration of Lactobacillus GG reduced the occurrence of atopic disease in offspring

Hywel C Williams
Evid Based Med 2001; 6: 178. [Extract] [Full text]  

Aetiology
Review: evidence does not support an association between allergen levels and risk for asthma

Brian J Smith and Richard Ruffin
Evid Based Med 2001; 6: 27. [Extract] [Full text]  

Therapeutics
Grass pollen immunotherapy for 3 to 4 years was still effective 3 years after being discontinued

James T Li
Evid Based Med 2000; 5: 46. [Extract] [Full text]